These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1445528)

  • 21. Initial weight loss as a predictor of response to obesity drugs.
    Dhurandhar NV; Blank RC; Schumacher D; Atkinson RL
    Int J Obes Relat Metab Disord; 1999 Dec; 23(12):1333-6. PubMed ID: 10643693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 23. Bitter pills, bad medicine.
    Golden F
    Time; 2001 Jun; 157(22):76. PubMed ID: 11432381
    [No Abstract]   [Full Text] [Related]  

  • 24. Report on the NIH Workshop on Pharmacologic Treatment of Obesity.
    Atkinson RL; Hubbard VS
    Am J Clin Nutr; 1994 Aug; 60(2):153-6. PubMed ID: 7913290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term weight control study: conclusions.
    Weintraub M
    Clin Pharmacol Ther; 1992 May; 51(5):642-6. PubMed ID: 1587079
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug-clinics. The hue and cry over central appetite suppressants!].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348
    [No Abstract]   [Full Text] [Related]  

  • 27. A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity.
    Goodall E; Oxtoby C; Richards R; Watkinson G; Brown D; Silverstone T
    Br J Psychiatry; 1988 Aug; 153():208-13. PubMed ID: 2908235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy of fenfluramine in treatment of obesity.
    Douglas JG; Gough J; Preston PG; Frazer I; Haslett C; Chalmers SR; Munro JF
    Lancet; 1983 Feb; 1(8321):384-6. PubMed ID: 6130379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of continuous and intermittent anorectic therapy in obesity.
    Munro JF; MacCuish AC; Wilson EM; Duncan LJ
    Br Med J; 1968 Feb; 1(5588):352-4. PubMed ID: 15508204
    [No Abstract]   [Full Text] [Related]  

  • 30. Anorexigen-induced cardiac valvulopathy and female gender.
    Naqvi TZ; Gross SB
    Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 6 months therapy with dexfenfluramine in obese patients: studies in the United Kingdom.
    Finer N; Craddock D; Lavielle R; Keen H
    Clin Neuropharmacol; 1988; 11 Suppl 1():S179-86. PubMed ID: 3052816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In memory of dexfenfluramine: R.I.P.
    Carruba MO; Nisoli E
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1193. PubMed ID: 9426390
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin.
    Rothman RB; Redmon JB; Raatz SK; Kwong CA; Swanson JE; Bantle JP
    Am J Cardiol; 2000 Apr; 85(7):913-5, A10. PubMed ID: 10758942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity.
    Langlois KJ; Forbes JA; Bell GW; Grant GF
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):289-96. PubMed ID: 4208343
    [No Abstract]   [Full Text] [Related]  

  • 35. Appetite suppressants for obesity.
    Budenholzer B
    J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of obesity. A call for prudence and professionalism.
    Kushner R
    Arch Intern Med; 1997 Mar; 157(6):602-4. PubMed ID: 9080914
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceutical treatment of obesity.
    Blackburn GL; Miller D; Chan S
    Nurs Clin North Am; 1997 Dec; 32(4):831-48. PubMed ID: 9386228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New agent for obesity management.
    Clemenson ND
    J Fam Pract; 1996 Sep; 43(3):224; author reply 225. PubMed ID: 8797741
    [No Abstract]   [Full Text] [Related]  

  • 39. Report links appetite suppressants with heart disease. FDA encourages reporting of like events.
    Am J Health Syst Pharm; 1997 Aug; 54(16):1785, 1788. PubMed ID: 9269513
    [No Abstract]   [Full Text] [Related]  

  • 40. The management of obesity.
    Court JM
    Drugs; 1972; 4(5):411-8. PubMed ID: 4568066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.